Secondary IDH1 resistance mutations and oncogenic IDH2 mutations cause acquired
- This topic has 0 replies, 1 voice, and was last updated 1 year, 7 months ago by
.
Viewing 1 post (of 1 total)
-
Posts
-
Secondary IDH1 resistance mutations and oncogenic IDH2 mutations cause acquired resistance to ivosidenib in cholangiocarcinoma
https://pubmed.ncbi.nlm.nih.gov/36056177/
Viewing 1 post (of 1 total)
- The forum ‘Chemotherapy & More’ is closed to new topics and replies.